Gamma Investing LLC Autolus Therapeutics PLC Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Gamma Investing LLC holds 10,628 shares of AUTL stock, worth $21,893. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,628
Previous 4,530
134.61%
Holding current value
$21,893
Previous $10.6 Million
35.59%
% of portfolio
0.04%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AUTL
# of Institutions
99Shares Held
163MCall Options Held
0Put Options Held
88.3K-
Wellington Management Group LLP Boston, MA27.1MShares$55.8 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$42.2 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$36.8 Million0.97% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$34.3 Million97.79% of portfolio
-
Armistice Capital, LLC New York, NY11MShares$22.7 Million0.26% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $187M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...